A huge thank you to the International Society for Stem Cell Research NeuroKaire (formerly Genetika+) had the privilege of participating in ISSCR 2024, where we exchanged ideas with experts from around the world and discovered the latest advancements in biotechnology. We remain more committed than ever to being at the forefront of innovation to improve mental health and help those in need. Thank you all for this amazing meeting and see you soon for more inspiring collaborations! #ISSCR2024 #NeuroKaire #MentalHealthInnovation #PrecisionMedecine
NeuroKaire (formerly Genetika+)
Biotechnology Research
Revolutionizing precision health in psychiatry and neurology
About us
NeuroKaire by Genetika+ a personalized medical testing tool to better treat depression by helping physicians find the best drug therapy for their patients. NeuroKaire uses innovative technology to predict the best drug treatment for each patient, enabling faster treatment, fewer side effects, and lower dosing.
- Website
-
http://www.neurokaire.com
External link for NeuroKaire (formerly Genetika+)
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Tel Aviv
- Type
- Privately Held
- Founded
- 2017
- Specialties
- Biotechnology, Neuroscience, Mental Illness, and ww
Locations
-
Primary
Get directions
126 Yigal Alon Street
Wing C, floor 2
Tel Aviv, IL
-
Get directions
78 John Miller Way
Kearny, New Jersey 07032, US
Employees at NeuroKaire (formerly Genetika+)
Updates
-
ISSCR 2024 conference is underway today! Orit Goldman and Moria Ben Yishay will be presenting our poster, #208, at 5:45 PM CEST today at #ISSCR2024 of the International Society for Stem Cell Research. We invite you to learn more about our recent work and discuss advancements in personalized treatments for depression. Hope to see you there! #NeuroKaire #ISSCR2024 #StemCellResearch #iPSCs #MentalHealthInnovation
-
-
NeuroKaire (formerly Genetika+) will be participating at the International Society for Stem Cell Research (ISSCR) 2024 in Hamburg, Germany. Orit Goldman Ph.D and Moria Ben Yishay Ph.D will present our latest advances in personalized mental health treatment at this global stem cell event. We will be there with our Scientific Advisory Board member Barbara Corneo. Join us to discover the latest scientific discoveries and technological innovations in stem cell research. We look forward to engaging with experts and exploring new solutions together. #NeuroKaire #MentalHealthInnovation #PrecisionMedicine #StemCellResearch #ISSCR2024
-
-
In a recent interview with B'nai B'rith International CEO Dan Mariashin and our Co-Founder and CEO, Dr. Talia Cohen Solal, Talia discusses how NeuroKaire (formerly Genetika+) leverages cutting-edge stem cell technology combined with advanced AI software to optimize drug treatment for patients. She also speaks about our exciting collaboration with NeuroSense Therapeutics on a promising new treatment for Alzheimer’s disease. Tune in to learn more about how NeuroKaire (formerly Genetika+) is pioneering innovations in personalized medicine. #podcast #artificialintelligence #StemCellTechnology #Alzheimersdiseaseawareness #NeuroKaire #precisionmedicine #MentalHealthinnovation https://lnkd.in/eucueYkJ
One Israeli Company's Quest to Revolutionize Healthcare
https://www.youtube.com/
-
Thank you Michal Fisher for the support, it was a pleasure meeting you at #BIO2024. At NeuroKaire (formerly Genetika+), we are proud of our advancements in precision medicine and are excited to collaborate with like-minded industry experts to improve patient outcomes. Together, we are transforming mental healthcare. #NeuroKaire #mentalhealthinnovation #precisionmedicine #collaboration
Back to introducing cool companies here :) I was excited to meet David Pattison, CPA at #BIOSanDiego. David works with NeuroKaire (formerly Genetika+), who are pioneering personalized medical solutions. NeuroKaire is a pioneer in personalized medicine solutions to optimize treatment for psychiatric and neurological diseases. With their innovative Brain-in-a-Dish technology, physicians can now identify the best treatment options tailored to each patient's unique needs. By leveraging patented technology to swiftly evaluate over 70 approved antidepressants and drug combinations against individual neurological biomarkers, NeuroKaire, is transforming healthcare. I was excited to meet David Pattison, CPA at #BIO2024 in SanDiego. David works with NeuroKaire (formerly Genetika+), who are pioneering personalized medical solutions to optimize treatment for psychiatric and neurological diseases. With their innovative Brain-in-a-Dish technology, physicians can now identify the best treatment options tailored to each patient's unique needs. By leveraging patented technology to swiftly evaluate over 70 approved antidepressants and drug combinations against individual neurological biomarkers, NeuroKaire is transforming healthcare. David spearheads partnerships with healthcare networks and biopharma organizations, accelerating the adoption of NeuroKaire's innovative technologies that unlock personalized treatment options and improve patient outcomes. His prior experience at Teva Pharmaceuticals honed his understanding of regulatory landscapes and ethical practices, while his 10 years at EY as a Life Sciences Global Business Development Executive helped diverse organizations navigate financial planning, partnerships, and collaborations. #Biotech #personalizedmedicine #Diagnostics #BusinessDevelopment #Investments
-
-
Continuing our commitment to advancing Alzheimer's Disease awareness and treatment, a collaborative poster presented by @NeuroSense Therapeutics at the @AD/PD 2024 Conference in March highlighting a promising start in our combined approach for developing personalized treatments for Alzheimer's Disease. https://lnkd.in/ezPEswqf By Shiran Zimri from NeuroSense Therapeutics #Alzheimers #BrainHealthinnovation #brainawareness #NeuroSense #ADPD2024 #precisionmedicine #personalizedhealth
-
There's still time to register for the meeting on "Innovation in Mental Health" this Wednesday, June 26th at 5:30 PM. Our Co-founder and CEO, Talia Cohen Solal, will be speaking on a panel led by Meta, 10D together with ICAR Collective, and Circles to discuss the role of technology in driving mental health innovation. #mentalhealthinnovation #precisionmedicine #technology #NeuroKaire
Now, more than ever, people’s mental health & wellbeing are important, online and offline. At Meta, we know how powerful connections can be, and I'm happy to join our partners 10D | ICAR Collective | NeuroKaire (formerly Genetika+) and Circles for an event focusing on #innovation in #MentalHealth. Happy Shavuot! 🙏 Gila Tolub Emmanuelle Lipski Talia Cohen Solal Irad Eichler RSVP link: https://lnkd.in/dHPA3pmV
-
-
In June, we emphasize the critical role of research and awareness in supporting individuals affected by Alzheimer’s disease and other cognitive disorders. Through our partnership with NeuroSense Therapeutics, we look forward to the opportunity to bring new and efficacious therapies to patients suffering from Alzheimer’s Disease sooner. Join us in our mission to advance understanding and develop effective solutions. #Alzheimersawareness #BrainAwareness #NeuroKaire #Research #BrainHealthInnovation #precisionmedicine #ENDALZ
-
-
Strategy day is an opportunity for the full team to get together, reflect on the past year’s achievements and challenges, and brainstorm on priorities and opportunities in the upcoming year. With our dynamic team and commitment to innovation, we’re gearing up for new challenges. Stay tuned for upcoming developments! #Neurokaire #StrategyDay #MentalHealthInnovation #PromisingFuture
-
-
It was a pleasure to participate in the IAmBIO podcast with Raffi Seyum and Jay Goodman at the 2024 BIO International Convention to share our perspective on how biotech breakthroughs converge with solutions for patients #BIO2024 #IamBIO #NeuroKaire #mentalhealthinnovation #precisionmedicine #personalizedhealth